Example: Heart Attack

Search clinical trials for: Voglibose

Total 23 results

NCT01993927

Completed

Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"

Conditions: Impaired Glucose Tolerance
NCT02049814

Completed

Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes

Conditions: Type 2 Diabetes Mellitus
NCT00663884

Completed

Glufast On Insulin Glargine Trial in Type 2 DM

Conditions: Diabetes Mellitus, Type 2
NCT01263509

Completed

Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

Conditions: Type 2 Diabetes Mellitus
NCT00411554

Completed

A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)

Conditions: Diabetes Mellitus, Non-Insulin-Dependent
NCT01263483

Completed

Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

Conditions: Type 2 Diabetes Mellitus
NCT00837577

Completed

MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)

Conditions: Diabetes Mellitus, Non-Insulin-Dependent
NCT01309698

Completed

Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT00654381

Completed

Japanese P III vs Voglibose and Placebo

Conditions: Diabetes Mellitus, Type 2
NCT00212017

Terminated

Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT

Conditions: Impaired Glucose Tolerance; Myocardial Infarction
NCT00724542

Unknown status

Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.

Conditions: Coronary Heart Disease; Impaired Glucose Tolerance
NCT02097342

Unknown status

Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus; Insulin Sensitivity/Resistance
NCT00970528

Completed

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

Conditions: Diabetes Mellitus, Type 2
NCT02287402

Completed

Postmarketing Clinical Study on AO-128

Conditions: Impaired Glucose Tolerance (IGT)
NCT01055652

Completed

Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients

Conditions: Type 2 Diabetes Mellitus
NCT00368134

Completed

To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes

Conditions: Diabetes Mellitus, Type 2
NCT01263496

Completed

Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan

Conditions: Type 2 Diabetes Mellitus
NCT01263470

Completed

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan

Conditions: Diabetes Mellitus, Type 2
NCT01242202

Completed

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients

Conditions: Type 2 Diabetes Mellitus
NCT01697592

Completed

Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

Conditions: Type 2 Diabetes Mellitus
NCT02475499

Completed

Incretin-based Drugs and Pancreatic Cancer

Conditions: Diabetes Mellitus, Type 2
NCT02476760

Completed

Incretin-based Drugs and Acute Pancreatitis

Conditions: Diabetes Mellitus, Type 2
NCT02456428

Completed

Incretin-based Drugs and the Risk of Heart Failure

Conditions: Type 2 Diabetes Mellitus